The estimated Net Worth of Jp Iii Llckkr Partners Iii,... is at least $368 Milión dollars as of 8 March 2013. Jp Iii owns over 3,750,000 units of Jazz Pharmaceuticals plc stock worth over $829,265 and over the last 13 years Jp sold JAZZ stock worth over $367,230,000.
Jp has made over 2 trades of the Jazz Pharmaceuticals plc stock since 2012, according to the Form 4 filled with the SEC. Most recently Jp sold 3,750,000 units of JAZZ stock worth $218,550,000 on 8 March 2013.
The largest trade Jp's ever made was selling 3,750,000 units of Jazz Pharmaceuticals plc stock on 8 March 2013 worth over $218,550,000. On average, Jp trades about 2,250,000 units every 121 days since 2012. As of 8 March 2013 Jp still owns at least 7,888 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Jp Iii stock trades at the bottom of the page.
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright a Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: